66
Participants
Start Date
December 29, 2017
Primary Completion Date
June 9, 2022
Study Completion Date
July 9, 2022
Steroid
Methylprednisolone 0.8 mg/kg/day (or equivalent corticosteroid doses) for 3 weeks（then tapering gradually, 8 weeks in total）
Rituximab
375mg/m2 for one dose
Cyclophosphamide
cyclophosphamide 2 mg/kg/day until inhibitor negative (no longer than five weeks)
Ethics Committee of Blood disease hospital, Chinese Academy of Medical Sciences, Tianjin
Qilu Hospital of Shandong University
OTHER
Tianjin First Central Hospital
OTHER
The Second Affiliated Hospital of Kunming Medical University
OTHER
Henan Cancer Hospital
OTHER_GOV
Zhang Lei, MD
OTHER